As a mere retail investor I do get mad at the way that we are taken for granted and ignored by the ASX, regulators and most companies. Having said that, life is tough and I am still in the market and hoping to make an honest quid.
MSB is a company with what I believe to be a very good product but unfortunately the road to commercialisation is long and complicated and requires commitment. For me, this stock is one to sit on and give them time to hopefully make me some good money in the (not too distant) future. I do however agree with those that are of the view that MSB could do a better job in keeping investors informed - it would be nice to be regularly advised on progress, no matter how small are the steps.
- Forums
- ASX - By Stock
- Previous announcements
As a mere retail investor I do get mad at the way that we are...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.712B |
Open | High | Low | Value | Volume |
$1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 55197 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 29782 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 55197 | 1.525 |
2 | 7393 | 1.520 |
5 | 63970 | 1.515 |
7 | 88983 | 1.510 |
4 | 60982 | 1.505 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 29782 | 3 |
1.540 | 111981 | 9 |
1.545 | 118548 | 7 |
1.550 | 107730 | 24 |
1.555 | 640 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online